{{Rsnum
|rsid=1131532
|Gene=TNFSF10
|Chromosome=3
|position=172506513
|Orientation=minus
|GMAF=0.3434
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=TNFSF10
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 43.5 | 46.8 | 9.7
| HCB | 31.1 | 48.9 | 20.0
| JPT | 43.2 | 38.6 | 18.2
| YRI | 59.0 | 37.7 | 3.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 31.1 | 48.9 | 20.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
[[rs1131532]] is a SNP in the tumor necrosis factor superfamily member 10 [[TNFSF10]] gene.

A study of 240 patients with early invasive ductal [[breast cancer]] followed for a median of 53 months concluded that [[rs1131532]](T;T) individuals had lower odds of being disease-free or distant-disease free, and for overall survival (hazard ratio 3.304, 4.757, and 6.459; p = 0.002, 0.001, and 0.009, respectively).{{PMID|19890662}}

{{PMID Auto
|PMID=18778477
|Title=Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival.
|OA=1
}}

{{PMID Auto
|PMID=20031590
|Title=The relation of genetic and environmental factors to systemic inflammatory biomarker concentrations.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}